SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-173040
Filing Date
2019-06-14
Accepted
2019-06-14 07:33:00
Documents
3
Period of Report
2019-06-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d753873d8k.htm 8-K 17034
2 EX-99.1 d753873dex991.htm EX-99.1 51561
3 GRAPHIC g753873page1.jpg GRAPHIC 3873
  Complete submission text file 0001193125-19-173040.txt   75169
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 19897581
SIC: 2834 Pharmaceutical Preparations